首页 | 本学科首页   官方微博 | 高级检索  
检索        

HPLC法测定大鼠血浆中DX-11的质量浓度
引用本文:刘冬洁,梁 宁,王林丽,郑 鑫,侯晓虹.HPLC法测定大鼠血浆中DX-11的质量浓度[J].沈阳药科大学学报,2013,30(3):192-196.
作者姓名:刘冬洁  梁 宁  王林丽  郑 鑫  侯晓虹
作者单位:(沈阳药科大学 制药工程学院,辽宁 沈阳 110016)
摘    要:目的建立测定大鼠血浆中DX-11N(β榄香烯13基)色氨酸]质量浓度的HPLC方法,并应用该法研究DX-11在大鼠体内的药动学。方法色谱柱:Kromasil C18柱(250 mm×4.6 mm,5μm),流动相:甲醇体积分数为0.2%的甲酸水溶液(体积比为75∶25),流速:1.0 mL.min-1,检测波长:220 nm,己烯雌酚作为内标物。结果 DX-11线性:0.2~20.0 mg.L-1,回归方程:Y=1.869×10-1ρ+9.830×10-2(r=0.998 1),定量下限:0.2 mg.L-1,回收率:84.1%~88.9%,日内和日间精密度均不大于10.2%。18只大鼠分别灌胃给予低、中、高3个剂量DX 12后,血浆中DX-11的tmax分别为(1.4±0.2)、(1.8±0.7)、(1.3±0.3)h,ρmax分别为(2.3±0.3)、(3.5±0.6)、(6.4±3.0)mg.L-1,t1/2分别为(1.7±0.7)、(2.3±1.0)、(1.4±0.8)h,AUC(0-∞)分别为(5.4±1.8)、(10.6±1.8)、(21.0±13.1)mg.h.L-1。结论建立并验证的HPLC法适用于DX-11在大鼠体内的药动学研究。

关 键 词:高效液相色谱法  DX-11  药动学
收稿时间:2012-5-23

Determination of DX-11 in rat plasma by HPLC
LIU Dong-jie,LIANG Ning,WANG Lin-li,ZHENG Xin,HOU Xiao-hong.Determination of DX-11 in rat plasma by HPLC[J].Journal of Shenyang Pharmaceutical University,2013,30(3):192-196.
Authors:LIU Dong-jie  LIANG Ning  WANG Lin-li  ZHENG Xin  HOU Xiao-hong
Institution:(School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China)
Abstract:Objective To establish a high performance liquid chromatographic method for determining the concentration of DX-11 N-(β-elemene-13-yl) tryptophan] in rat plasma. Methods The chromatographic separation was performed on a Kromasil C18 column (250 mm×4.6 mm, 5 μm), and a mobile phase consisted of methanol -0.2% formic acid (V∶V = 75∶25) at a flow rate of 1.0 mL·min-1. The detection wavelength was set at 220 nm, and the diethylstilbestrol was used as the internal standard. Results A good linearity was obtained from 0.2 mg·L-1 to 20.0 mg·L-1 of DX-11 in rat plasma with a regressive equation of Y = 1.869×10-1ρ+9.830×10-2 (r = 0.998 1). The limit of detection was 0.2 mg·L-1and the recoveries were ranging from 84.1% to 88.9%. The RSDs of intra- and inter-day were less than 10.2%. The pharmacokinetic parameters of DX-11 in rat plasma after i.g. administration of different doses of DX-12 to 18 healthy rats were as follows: tmax = (1.4 ± 0.2), (1.8 ± 0.7), and (1.3 ± 0.3) h, ρmax = (2.3 ± 0.3), (3.5 ± 0.6), and (6.4 ± 3.0) mg·L-1, t1/2 = (1.7 ± 0.7), (2.3 ± 1.0), and (1.4 ± 0.8) h, AUC(0-∞) = (5.4 ± 1.8), (10.6 ± 1.8), and (21.0 ± 13.1) mg·h·L-1, respectively. Conclusion The established method would be applied for the pharmacokinetic study of DX-11 in rat plasma.
Keywords:HPLC" target="_blank">HPLC')">HPLC  DX-11  pharmacokinetics" target="_blank">')">pharmacokinetics
点击此处可从《沈阳药科大学学报》浏览原始摘要信息
点击此处可从《沈阳药科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号